COG AALL1331: A Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND# 117467, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)

      Project: Research project

      Project Details

      StatusFinished
      Effective start/end date10/16/1512/31/19

      Funding

      • Children's Hospital of Philadelphia (WO FP#: FP00017990_SUB24_01)
      • Amgen, Inc. (WO FP#: FP00017990_SUB24_01)